We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAYS:NASDAQPaysign, Inc. analysis

Data as of Sep 9, 2026 - not real-time

Latest price
$12.94
Risk: high
9/10High risk

Summary

Paysign, Inc. trades at $12.94, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 41.9%. Relative strength is 57.2 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $12.08 and resistance at $14.43.
Valuation screens as overvalued: a P/E of 49.8 sits above the sector average of 33.3. Revenue is growing at 48.1% on a 15.7% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 83.8%, a beta of 0.93 and a maximum drawdown of 49.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top market events

  • PaySign Inc PAYS raises full-year guidance amid robust demand, with adjusted EBITDA up 113% and a strong pipeline of...
  • Yahoo Finance1monPaySign Inc PAYS Q2 2026 Earnings Call Highlights: Record Revenue Surges 48% as Patient .
  • Seeking Alpha1monPaysign, Inc. PAYS Q2 2026 Earnings Call TranscriptGood afternoon. My name is Kevin, and I'll be your...

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 6.70
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 49.8 versus sector average of 33.3
  • Trading above the 200-day average of 6.70

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 49.8 versus sector average of 33.3
  • Profit margin of 15.7% is healthy
  • Revenue growth of +48.1%

Key metrics

Financial health

Revenue Growth48.10%
Profit Margin15.67%
P/E Ratio49.8
ROE30.82%
ROA4.34%
Debt/Equity9.49
P/B Ratio12.1
Op. Cash Flow$74.9M
Free Cash Flow$14.3M
Industry P/E33.3

Technical analysis

TrendBullish
RSI57.2
Support$12.08
Resistance$14.43
MA 20$13.20
MA 50$10.86
MA 200$6.70
MACDBearish
VolumeIncreasing
Fear & Greed Index92.38

Valuation

Fair Value$9.11
Target Price$13.10
Upside/Downside1.24%
GradeOvervalued
TypeGrowth

Risk assessment

Beta0.93
Volatility83.84%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.